Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
47
A new study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants aged 60 and older to elaborate risk across sex and across the intersection of sex and race. The study, the largest ...
Jul 21, 2023
1
16
An international collaboration steered by David Cortez, Richard N. Armstrong, Ph.D. Chair for Innovation in Biochemistry, explored how cells tolerate DNA damage and genome instability—and they arrived at conclusions that ...
May 3, 2023
0
42
For most people, respiratory syncytial virus (RSV) is about as dangerous as the common cold. But for children younger than six months old, and for people whose immune defenses have been weakened by age, disease, chemotherapy ...
Mar 10, 2023
0
85
Millions of children worldwide are under legal guardianship of the state, often due to abuse, neglect, parental death or other circumstances—leaving governments to determine how best to care for them. The Bucharest Early ...
Sep 13, 2022
0
51
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Jul 22, 2022
0
58
A recently published study reveals new insights into how gastric cancer develops and suggests a preventive treatment.
Jul 1, 2022
0
121
The human brain is organized in functional networks—connected brain regions that communicate with each other through dedicated pathways. That is how we perceive our senses, how the body moves, how we are able to remember ...
Apr 12, 2022
0
177
Kathleen DelGiorno, assistant professor of cell and developmental biology, her lab and collaborators at the Salk Institute have discovered some of the specific signaling molecules involved in tumor progression in pancreatic ...
Apr 1, 2022
0
76
In the clinical care of people living with HIV, various types of blood cells are routinely counted to assess the immune system, among them CD4+ cells, or T helper cells, and CD8+ cells, or cytotoxic T cells.
Mar 18, 2022
0
125
